Tang, Yi

Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study

Jia, L., Du, Y., Chu, L., Zhang, Z., Li, F., Lyu, D., Li, Y., Li, Y., Zhu, M., Jiao, H., et al. (2020) · The Lancet Public Health

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 1,829

Dementia in China: epidemiology, clinical management, and research advances

Jia, L., Quan, M., Fu, Y., Zhao, T., Li, Y., Wei, C., Tang, Y., Qin, Q., Wang, F., Qiao, Y., et al. (2020) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 875

The cost of Alzheimer's disease in China and re‐estimation of costs worldwide

Jia, J., Wei, C., Chen, S., Li, F., Tang, Y., Qin, W., Zhao, L., Jin, H., Xu, H., Wang, F., et al. (2018) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 752

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need

Babulal, G. M., Quiroz, Y. T., Albensi, B. C., Arenaza‐Urquijo, E., Astell, A. J., Babiloni, C., Bahar‐Fuchs, A., Bell, J., Bowman, G. L., Brickman, A. M., et al. (2019) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 528

TREM2, microglia, and Alzheimer’s disease.

Qin, Q., Teng, Z., Liu, C., Li, Q., Yin, Y., & Tang, Y. (2021) · Mechanisms of Ageing and Development

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 219

TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target

Li, R.-Y., Qin, Q., Yang, H.-C., Wang, Y.-Y., Mi, Y.-X., Yin, Y.-S., Wang, M., Yu, C.-J., & Tang, Y. (2022) · Molecular Neurodegeneration

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 204

Prediction of Alzheimer's disease using multi-variants from a Chinese genome-wide association study

Jia, L., Li, F., Wei, C., Zhu, M., Qu, Q., Qin, W., Tang, Y., Shen, L., Wang, Y., Shen, L., et al. (2021) · Brain

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 67

Associations between Plasma Ceramides and Cognitive and Neuropsychiatric Manifestations in Parkinson’s Disease Dementia

Xing, Y., Tang, Y., Zhao, L., Wang, Q., Qin, W., Ji, X., Zhang, J., & Jia, J. (2016) · Journal of the Neurological Sciences

Parkinson's Disease Mechanisms and TreatmentsSphingolipid Metabolism and Signaling

Cited by 63

Machine learning in Alzheimer’s disease drug discovery and target identification

Geng, C., Wang, Z., & Tang, Y. (2024) · Ageing Research Reviews

Computational Drug Discovery MethodsAlzheimer's disease research and treatments

Cited by 34

Tracking cognitive trajectories in older survivors of COVID-19 up to 2.5 years post-infection

Liu, Y.-H., Wu, Q.-X., Wang, Q.-H., Zhang, Q.-F., Tang, Y., Liu, D., Wang, J.-J., Liu, X.-Y., Wang, L.-R., Li, L., et al. (2024) · Nature Aging

Long-Term Effects of COVID-19COVID-19 Clinical Research Studies

Cited by 20